The use of cisplatin as a potential radiosensitizer in nasopharyngeal carcinoma (NPC) has produced encouraging results in clinical trials. In order to provide information on improving the design of clinical treatments, we investigated the effect of cisplatin dose, and the time interval and sequence between administration of cisplatin and radiation on cell survival of two NPC cell lines, CNE1 and SUNE1. When cisplatin was applied first, an exposure time of 24 h resulted in up to 2.6-fold increase in cell death and 7-fold increase in radiation effect (cell survival after cisplatin/cell survival after cisplatin plus radiation) in the cisplatin-radiation combination treatment compared to the cells treated with cisplatin for 4 h. When radiation ...
A three-arm randomized trial was performed to assess the acute and late toxicity and the impact on s...
Head and neck cancer is the sixth most common cancer, with increasing incidence and a 5-year surviva...
Current clinical studies support the role of neoadjuvant cisplatin administration prior to curative ...
Copyright © Institute of Physics and IOP Publishing Limited 2009.The aim of the present work was to ...
rent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma, concluded th...
We aimed to compare the long-term survival outcomes and acute toxicity of cisplatin administered wee...
Background and Methods. Cisplatin (cisdiamminedichloroplatinum) has been reported to enhance the cel...
Abstract Evidence on the impact of chemotherapy on radiotherapy-induced second malignant neoplasms i...
Aims: Predictors of outcome after radiotherapy alone for nasopharyngeal carcinoma (NPC) are now avai...
Cisplatin (cis-cuammmedichloroplatinum(II)) is a highly effective chemotherapeutic drug given either...
textabstractIn this thesis studies of weekly administration of cisplatin are presented. Weekly admin...
A randomised phase II trial was initiated to explore the feasibility of concomitant cisplatin and ra...
Shiping Yang,1,2,* Xiaoling Fu,3,* Guang Huang,2 Junni Chen,2 Shishi Luo,4 Zhenping Wang,4 Fanzhong ...
<p><b>(A)</b> Vero cells were pretreated with L-TH (120 nM) for different exposure time before incub...
© 2019 The American Laryngological, Rhinological and Otological Society, Inc. Objective: To determin...
A three-arm randomized trial was performed to assess the acute and late toxicity and the impact on s...
Head and neck cancer is the sixth most common cancer, with increasing incidence and a 5-year surviva...
Current clinical studies support the role of neoadjuvant cisplatin administration prior to curative ...
Copyright © Institute of Physics and IOP Publishing Limited 2009.The aim of the present work was to ...
rent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma, concluded th...
We aimed to compare the long-term survival outcomes and acute toxicity of cisplatin administered wee...
Background and Methods. Cisplatin (cisdiamminedichloroplatinum) has been reported to enhance the cel...
Abstract Evidence on the impact of chemotherapy on radiotherapy-induced second malignant neoplasms i...
Aims: Predictors of outcome after radiotherapy alone for nasopharyngeal carcinoma (NPC) are now avai...
Cisplatin (cis-cuammmedichloroplatinum(II)) is a highly effective chemotherapeutic drug given either...
textabstractIn this thesis studies of weekly administration of cisplatin are presented. Weekly admin...
A randomised phase II trial was initiated to explore the feasibility of concomitant cisplatin and ra...
Shiping Yang,1,2,* Xiaoling Fu,3,* Guang Huang,2 Junni Chen,2 Shishi Luo,4 Zhenping Wang,4 Fanzhong ...
<p><b>(A)</b> Vero cells were pretreated with L-TH (120 nM) for different exposure time before incub...
© 2019 The American Laryngological, Rhinological and Otological Society, Inc. Objective: To determin...
A three-arm randomized trial was performed to assess the acute and late toxicity and the impact on s...
Head and neck cancer is the sixth most common cancer, with increasing incidence and a 5-year surviva...
Current clinical studies support the role of neoadjuvant cisplatin administration prior to curative ...